Clinical Trials Browser

Completed × Neuroblastoma × Immunotherapy × Clear all

NCT00186862 2008-06-03

Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma

Phase 1 Completed

Neuroblastoma